Skip to main content
. 2021 May 8;64(8):1725–1736. doi: 10.1007/s00125-021-05456-w

Table 1.

Baseline demographics and metabolic characteristics

Characteristic CSII
(n=204)
MDI
(n=211)
p value
Age at diagnosis (years) 15 (10–26) 21 (12–33) <0.001
Age at study entry (years) 38 (29–48) 43 (31–53) <0.001
Diabetes duration (years) 18 (11–25) 16 (8–27) 0.63
Sex M:F (%M) 76:128 (37.3) 90:121 (42.7) 0.31
Weight (kg) 78.9 (67.6–90.3) 79.5 (67.6–91.5) 0.84
BMI (kg/m2) 26.9 (24.0–31.2) 27.1 (24.2–30.4) 0.97
HbA1c (mmol/mol) 66 (58–74) 67 (60–80) <0.05
HbA1c (%) 8.2 (7.5–8.9) 8.3 (7.6–9.5) <0.05
SIMD 4 (3–5) 3 (2–5) <0.05
Cholesterol (mmol/l) 4.7 (4.2–5.2) 4.8 (4.2–5.4) 0.14
Creatinine (μmol/l) 73 (67–83) 74 (68–84) 0.26
Systolic BP (mm/Hg) 128 (118–140) 128 (120–138) 0.95
Diastolic BP (mm/Hg) 78 (73–84) 77 (71–83) <0.001
Smoking status 0.20
 Non-smoker 141 (69) 131 (62)
 Ex-smoker 48 (24) 55 (26)
 Current smoker 15 (7) 25 (12)
Baseline diabetic retinopathy grading 0.10
 R0 93 (45.6) 100 (47.4)
 R1 109 (53.4) 101 (47.9)
 R2 0 2 (0.9)
 R3 2 (1.0) 8 (3.8)
 R4 Excluded Excluded

Data are median (IQR) or number (%) unless otherwise indicated. p values were calculated using unpaired t test for continuous numerical data and χ2 test or Fisher’s exact test for categorical data. Baseline grading indicates the overall baseline retinopathy grading for each individual. As retinal data were available for both eyes, the more severe retinal grading outcome for that individual was used as the baseline

F, female; M, male